Browsing Tag
Australia
722 posts
Algorae Pharmaceuticals (ASX: 1AI) raises A$4m to fund dual commercial and AI drug discovery growth strategy
Algorae Pharmaceuticals (ASX: 1AI) raises A$3.99m to scale AlgoraeRx commercial portfolio and advance AlgoraeOS AI drug pipeline. Read the full strategic analysis.
Trump’s Iran speech sends crude to six-year high, gas tops $4 nationwide
U.S. crude oil surged nearly $12 per barrel on April 3, 2026, its largest one-day gain since 2020, after Trump pledged more Iran strikes with no Strait of Hormuz reopening plan.
Etherstack (ASX: ESK) lands Home Affairs contract for digital wireless infrastructure across Australian ports and airports
Etherstack (ASX: ESK) secures a A$9m multi-year contract with Australia's Department of Home Affairs. What it means for ESK investors. Read more.
Albanese warns Australians of months-long economic pain from Middle East war as petrol prices hit historic highs
Australian PM Anthony Albanese warns Middle East war will cause months of economic shocks; fuel excise halved and public transport urged amid historic petrol price surge.
Anthropic signs Australia MOU, pledging AI safety collaboration, research investment and renewable-powered data centre expansion
Anthropic signs Australia AI MOU with Dario Amodei in Canberra, pledging safety collaboration, AUD$3m research, and renewable data centre commitments. Read more.
What IFF just won in Australia and New Zealand could quietly change how heart-health foods are marketed
IFF has secured a new soy protein heart health claim in Australia and New Zealand. Read why this regulatory move could matter for functional food growth.
What this small Australia acquisition reveals about Arthur J. Gallagher & Co.’s bigger strategy (NYSE: AJG)
Read how Arthur J. Gallagher & Co.’s latest Australia acquisition reveals the bigger long-term strategy behind AJG’s global insurance expansion.
Clover Biopharmaceuticals stock in focus as new RSV re-vaccination data targets a gap GSK has not solved
Clover Biopharmaceuticals says new RSV re-vaccination data beat Arexvy in older adults. Read what this could mean for the adult vaccine market.
TZ Limited (ASX: TZL) loses CEO eight days after appointment as investor confidence tests debt-heavy balance sheet
TZ Limited (ASX: TZL) CEO resigns 8 days after appointment as debt deadline looms and shares fall 23%. Read our analysis of what this means for investors.
‘Not our war’: Germany, Japan, Italy flatly reject Trump’s Hormuz warship demand
Germany, Japan, Italy and Australia reject Trump's demand for warships at the Strait of Hormuz as the US-Israel war on Iran enters its third week.